Daniel Levangie is an experienced executive with senior operating experience in the field of medical devices and in vitro diagnostics. Mr. Levangie is currently the Chief Executive Office of Cerevasc, LLC and co-founder and Managing Partner of ATON Partners, LLC, a Boston based private investment and management consulting firm. Most recently, Mr. Levangie was Chief Executive Officer of Dune Medical Devices and co-founder and Managing Partner of Constitution Medical Investors, Inc. (CMI) a Boston-based private investment and product development firm acquired by Roche Diagnostics Corporation in July 2013. Prior to that Mr. Levangie was Chief Executive Officer of Keystone Dental, Inc., a Warburg Pincus portfolio company involved in dental reconstruction technologies and Chairman of the Board of ev3.
Beginning in 1992 Mr. Levangie held a variety of executive management positions with Cytyc Corporation until the acquisition of Cytyc Corporation by Hologic, Inc. in October of 2007. Those positions included Executive Vice President and Chief Operating Officer, Chief Executive Officer and President of Cytyc Health Corporation, Executive Vice President and Chief Commercial Officer and President, Cytyc Surgical Products Division.
Prior to joining Cytyc Corporation in 1992, Mr. Levangie held a number of sales, marketing and management positions with Abbott Laboratories, North Chicago, IL.
Mr. Levangie resides in Boston, MA with his wife Joan, and is a member of the Board of Directors of Exact Sciences, Inc., Liposcience, Inc., Dune Medical Devices, LTD. and is Lead Director of Insulet Corporation. Mr. Levangie, a graduate of the College of Pharmacy of Northeastern University in Boston, is a member of the Advisory Board of the Barnett Institute of Northeastern University and is a trustee of Excel Charter School.
Managing Partner ATON Partners, LLC
75 Arlington Street, Suite 500
Boston, MA 02116
Patrick Sullivan is an experienced executive with an outstanding track record in managing early stage medical device and diagnostics ventures through all phases of growth. He is currently Managing Partner of ATON Partners, LLC and is President & Chief Executive Officer of Insulet Corporation (PODD). Prior to these roles Mr. Sullivan served as Chairman & CEO of Constitutional Medical Investors from 2008 until its sale to Roche Diagnostics Hematology in July 2013. From 1991 through 2007 Mr. Sullivan served in a variety of senior executive positions with Cytyc Corporation including Chairman, President and Chief Executive Officer until the acquisition of Cytyc Corporation by Hologic Corporation in October of 2007. Prior to joining Cytyc, Mr. Sullivan was employed in several senior marketing positions by Abbott Laboratories, a diversified healthcare company, and was a consultant with McKinsey & Company, an international management-consulting firm. Mr. Sullivan holds a Bachelor of Science degree, with Distinction, from the United States Naval Academy and a Master of Business Administration degree, with Distinction, from Harvard Business School. Mr. Sullivan is a Director of CereVasc, Perkin-Elmer Corporation and Theragenics Corporation.
Add content here
Add content here
Carl Heilman MD, is the Neurosurgeon-in-Chief at Tufts Medical Center. He is Chairman of the Department of Neurosurgery as well as a Professor at Tufts University School of Medicine. Internationally known for neurosurgical excellence, Dr. Heilman is the past president of the Boston Society of Neurology and Psychiatry, the New England Neurosurgical Society, the Society of University Neurosurgeons, and the North American Skull Base Society. He is currently one of the 14 Directors of the American Board of Neurological Surgeons.